(Q44630202)

4 December 2017

title

Hippocampal serotonergic system is involved in anxiety-like behavior induced by corticotropin-releasing factor (English)

1 reference

4 December 2017

Yoshifumi Kagamiishi

1

1 reference

4 December 2017

Tsuneyuki Yamamoto

2

1 reference

4 December 2017

Shigenori Watanabe

3

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

4 December 2017

21 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14575894

full work available at URL

24 March 2024

number of pages

10

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0006899303035959?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

https://api.elsevier.com/content/article/PII:S0006899303035959?httpAccept=text/plain

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

24 March 2024

1 reference

4 December 2017

volume

991

1 reference

4 December 2017

issue

1-2

1 reference

4 December 2017

page(s)

212-221

1 reference

Evidence that corticotropin-releasing factor within the extended amygdala mediates the activation of tryptophan hydroxylase produced by sound stress in the rat.

4 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Pharmacological and chemical properties of astressin, antisauvagine-30 and alpha-helCRF: significance for behavioral experiments.

24 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

24 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat.

24 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release

24 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.

24 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Anxiolytic effects of cytotoxic hippocampal lesions in rats

24 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

The effect of corticotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats

24 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Serotonin-1A anxiolytics: an overview

24 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Novel environment and cat odor change GABA and 5-HT release and uptake in the rat.

24 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests

24 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone

24 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II.

24 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress

24 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

5HT drugs in animal models of anxiety

24 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

24 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action

24 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity

24 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Involvement of the dorsal hippocampus in mediation of the antianxiety action of tandospirone, a 5-hydroxytryptamine1A agonistic anxiolytic

24 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis.

24 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Non-peptidic CRF1 receptor antagonists for the treatment of anxiety, depression and stress disorders

24 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action

24 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

24 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Effects of Corticotropin-Releasing Factor on Neuronal Activity in the Serotonergic Dorsal Raphe Nucleus

24 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Corticotropin-releasing factor, norepinephrine, and stress

24 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis

24 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity

24 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent

24 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

24 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models.

24 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Increased anxiety of mice lacking the serotonin1A receptor

24 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo

24 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress

24 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

24 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.

24 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary

24 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.

24 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze

24 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT1A agonist, in three stress paradigms: immobilization, forced swim and conditioned fear

24 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Conflict behavior and dynamics of monoamines of various brain nuclei in rats.

24 March 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats

24 March 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.

24 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity.

24 March 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex

24 March 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Sustained 5-hydroxytryptamine release-inhibitory and anxiolytic-like action of the partial 5-HT1A receptor agonist, buspirone, after prolonged chronic administration

24 March 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons

24 March 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment

24 March 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study

24 March 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.

24 March 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).

24 March 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Comparison of Stress‐induced Changes in Noradrenergic and Serotonergic Neurons in the Rat Hippocampus Using Microdialysis

24 March 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

24 March 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus.

24 March 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

24 March 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze

24 March 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex.

24 March 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

24 March 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.

24 March 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.021

24 March 2024

Identifiers

1 reference

4 December 2017

1 reference